Sleep medicine pharmacotherapeutics overview: Today, tomorrow, and the future (Part 2: Hypersomnia, parasomnia, and movement disorders)

Research output: Contribution to journalArticlepeer-review

Abstract

Over the past 10 years, significant strides have been made in therapeutics for sleep disorders. In this second installment of a two-part review series, we discuss the current evidence surrounding the mechanisms of actions, indications, efficacy, and adverse side effects associated with the current over-the-counter and pharmacotherapeutics for hypersomnia, parasomnias, and movement disorders of sleep.

Original languageEnglish (US)
Pages (from-to)242-251
Number of pages10
JournalCHEST
Volume143
Issue number1
DOIs
StatePublished - Jan 2013

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Sleep medicine pharmacotherapeutics overview: Today, tomorrow, and the future (Part 2: Hypersomnia, parasomnia, and movement disorders)'. Together they form a unique fingerprint.

Cite this